Lv5
1026 积分 2022-12-28 加入
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
1个月前
已完结
Treating cancer with selective CDK4/6 inhibitors
1个月前
已完结
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
2个月前
已完结
Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway by voacamine suppress breast cancer progression
2个月前
已完结
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
5个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
5个月前
已完结
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
8个月前
已完结
Assessment and Influencing Factors of Post‐Competency Among Nursing Master’s Degree Graduates in China: A Multivariate Analysis Approach
8个月前
已完结
Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development
9个月前
已完结
Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands
9个月前
已完结
皖公网安备34019202002308
